Measurement of daily physical activity in patients with cystic fibrosis;Évaluation de l'activité physique quotidienne de patients adultes atteints de mucoviscidose

Revue des Maladies Respiratoires

Volumn 22, Issue 1, 2005, Pages 63-69

  Fournier, C ^a   Bosquet, L ^b   Leroy, S ^a   Perez, T ^a   Neviere, R ^a   Wallaert, B ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Faculte des Sciences du Sport   (France)

Author keywords

Accelerometer; Clinical exercise testing; Cystic fibrosis; Physical activity; Spirometry

Indexed keywords

ACCELEROMETER; ADULT; ARTICLE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DYSPNEA; EXERCISE TEST; FEMALE; GENE MUTATION; HUMAN; LUNG FUNCTION TEST; MALE; MONITOR; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; SPIROMETRY; MOTOR ACTIVITY; PATHOPHYSIOLOGY;

ADULT; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; MOTOR ACTIVITY; PROSPECTIVE STUDIES;

EID: 16444375907     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(05)85437-3     Document Type: Article

References (15)

1. Observatoire National de la Mucoviscidose. Données 2001.
2. Kerem E, Reisman J, Corey M, Canny GJ, Levison H: Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992; 327: 1244-5.
3. Nixon PA, Orenstein DM, Kelsey SF, Doershuk CF: The prognostic value of exercice testing in patients with cystic fibrosis. N engl J Med 1992; 327: 1785-88.
4. Bouten CV, Verboeket-van de Venne WP, Westerterp KR, Verduin M, Janssen JD: Daily physical activity assessment: comparison between movement registration and doubly labeled water. J Appl Physiol 1996; 81: 1019-26.
5. Ekelund U, Sjostrom M, Yngve A, Poorrvliet E, Nilsson A, Froberg K, Wedderkopp N, Westerterp K: Physical activity assessed by activity monitor and doubly labeled water in children. Med Sci Sports Exerc 2001; 33: 275-81.
6. Matthews CE, Ainsworth BE, Thompson RW, Bassett DR Jr: Sources of variance in daily physical activity levels as measured by an accelerometer. Med Sci Sports Exerc 2002; 34: 1376-81.
7. Freedson PS, Melanson E, Sirard J: Calibration of the Computer Science and Applications, Inc. accelerometer. Med Sci Sports Exerc 1998; 30: 777-81.
8. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernauk JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur respir J Suppl 1993; 16: 5-40.
9. Moorcroft AJ, Dodd ME, Webb AK: Exercice testing and prognosis in adult cystic fibrosis. Thorax 1997; 52: 291-3.
10. Moorcroft AJ, Dodd ME, Webb AK: Long-term change in exercise capacity, body mass, and pulmonary function in adults with cystic fibrosis. Chest 1997; 111: 338-43.
11. Aguilaniu B, Flore P, Maître J, Page E: Usage diagnostique de la consommation d'oxygène et des échanges gazeux au cours de l'exercice. Rev Mal Respir 1998; 13: 575-87.
12. McKone EF, Barry SC, Fitzgerald MX, Gallagher CG: Reproductibility of maximal exercise ergometer testing in patients with cystic fibrosis. Chest 1999; 116: 363-8.
13. Hamosh A, Corey M: Correlations between genotype and phenorype in patients with cystic fibrosis. N Engl J Med 1993; 329: 1308-13.
14. Bar-Or O: Juvenile obesity, Physical activity, and lifestyle changes. The physician and sportsmedicine 2000; 28: 11.
15. Berthouze SE, Minaire PM, Castells J, Busso T, Vico L, Lacour JR: Relationship between mean habitual daily energy expenditure and maximal oxygen uptake. Med Sci Sports exerc 1995; 27: 1170-9.